Cellino
Edit

Cellino

http://cellinobio.com/
Last activity: 13.02.2024
Active
Categories: CargoEngineeringHealthTechHumanITLearnPersonalPlatformResearchTechnology
Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies. Cellino’s vision is to enable healthier lives worldwide with personalized treatments derived from induced pluripotent stem cells (iPSCs), which can serve as the basis for therapies for a host of chronic degenerative diseases, including vision loss and Parkinson's disease.
Followers
928
Followers
8.8K
Mentions
22
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $171M
Founded date: 2017

Investors 5

Funding Rounds 3

DateSeriesAmountInvestors
27.01.2022Series A$80M-
01.02.2021Seed$16MKhosla Ven...
--$75M-

Mentions in press and media 22

DateTitleDescription
13.02.2024TechCrunch Early Stage 2024 updated agenda with Sequoia, YC, Lightspeed, Felicis, NFX and more!TechCrunch Early Stage returns to Boston on April 25, 2024, and the agenda for our flagship founder event is almost complete. We’re excited to share this not-so-sneaky sneak peek at some of the fantastic speakers and sessions we have on tap...
12.09.2022How WhiteLab Genomics is using AI to aid gene and cell therapy developmentFrench biotech company WhiteLab Genomics has raised $10 million in funding for an AI platform designed to aid the discovery and development of genomic therapies. Founded out of Paris in 2019, recent Y Combinator (YC) graduate WhiteLab Genom...
25.01.2022Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy ManufacturingCellino Biotech, Inc., an autonomous cell therapy manufacturing company, today announced the completion of a Series A financing of $80 million, led by the impact investment arm of Bayer AG —Leaps by Bayer— 8VC, and Humboldt Fund. New invest...
25.01.2022Startup Battlefield Winner Cellino grabs $80M Series ACellino Bio’s founder Nabiha Saklayen didn’t initially intend to enter TechCrunch Disrupt 2021’s Startup Battlefield – it was her PR advisor who threw the startup’s name in the ring as a wildcard entry. But after a busy weekend for the team...
25.01.2022This Stem Cell Manufacturing Startup Just Raised An $80 Million War Chest To Revolutionize MedicineNabiha Saklayen, CEO and co-founder of Cellino Cellino
24.09.2021And the winner of Startup Battlefield is…Natasha and Mary Ann and Alex were all aboard this week under the guidance of Chris and Grace, along with TechCrunch’s Neesha Tambe. Neesha is one of our best and is the leading light of the Startup Battlefield event at our yearly Disrupt c...
23.09.2021Meet the 5 judges who will pick the 2021 winner of TechCrunch Disrupt’s Startup BattlefieldThe battle to win Startup Battlefield began long before TechCrunch Disrupt kicked off Tuesday. Startup founders from all over the world applied to what has been described as the most competitive batch in TechCrunch history. Twenty startups ...
23.09.2021And the winner of Startup Battlefield at Disrupt 2021 is… CellinoWe started this competition with 20 impressive startups. After three days of fierce pitching in the virtual yet incredibly competitive Startup Battlefield arena, we have a winner. The startups taking part in the Startup Battlefield have all...
23.09.2021Daily Crunch: Cellino wins TechCrunch Disrupt Startup Battlefield 2021To get a roundup of TechCrunch’s biggest and most important stories delivered to your inbox every day at 3 p.m. PDT, subscribe here. Hello and welcome to Daily Crunch for September 23, 2021. We just put the final bow on Disrupt, which went ...
22.09.2021Cellino is using AI and machine learning to scale production of stem cell therapiesCellino, a company developing a platform to automate stem cell production, presented today at TechCrunch Disrupt 2021’s Startup Battlefield to detail how its system, which combines AI technology, machine learning, hardware, software — and y...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In